Health, Policy & Grants
HHS Opens $1 Million Competition to Update Women's Preventive-Care Guidance
The WISH program would fund one organization to convene experts, review evidence and improve how HRSA-supported preventive-service recommendations reach patients and clinicians.
One award for a national coalition
The Health Resources and Services Administration opened a fiscal 2027 funding opportunity of up to $1 million for the Women's Initiative for Screening and Health. HHS expects to select one organization to manage a multidisciplinary coalition that reviews and updates HRSA-supported Women's Preventive Services Guidelines. The notice is a competition, not an award to a named recipient.
Who must be at the table
The recipient would convene at least ten experts spanning women's health, primary care, public health, preventive medicine, behavioral health, patient groups and organizations serving medically underserved women. HHS also expects evidence reviews using National Academies standards and communication tailored to communities with limited resources. The final grant documents control eligibility and performance obligations.
Why the guidance matters
Federal law generally requires many non-grandfathered private health plans to cover HRSA-supported preventive services without patient cost sharing. A guideline update can therefore influence both clinical practice and insurance coverage, but it does not replace individualized medical advice. Recommendations must distinguish the strength of evidence, the population studied and possible harms as well as benefits.
Application timing
Applications are due January 8, 2027 at 11:59 p.m. Eastern through Grants.gov under opportunity HRSA-27-072. Applicants need active federal registrations. Organizations considering the award should compare the public announcement with the complete notice, including budget, reporting and review criteria, and allow time for registration issues before the deadline.
How to evaluate the result
The initiative should ultimately be judged by transparent evidence reviews, conflict-of-interest safeguards, clear recommendation language and measurable dissemination to clinicians and patients. The November 6 action starts a procurement and guideline process; it does not itself change a covered service. Later award notices and published recommendations will show the program's actual effect.
Primary evidence
Reporting note: This independently composed article is based on the linked primary records. Publication and event dates are stated separately. Agency claims are identified as such; an allegation, charge or scheduled event is not presented as a finding, conviction or completed event. Readers should consult the official record for amendments and later action.